Modeling Impaired Judgement in Cocaine Abusers - 6
NCT00015236 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2017-01-12
Summary
The purpose of this study is for the modeling of impaired judgement in cocaine abusers.
Conditions
- Cocaine-Related Disorders
- Substance-Related Disorders
Interventions
- BEHAVIORAL
-
Amantadine
Sponsors & Collaborators
-
New York MDRU
collaborator OTHER -
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
John Rotrosen, M.D. · New York MDRU
Study Design
- Purpose
- PREVENTION
- Masking
- NONE
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1997-03-31
Countries
- United States
Study Locations
More Related Trials
-
IV Cocaine Abuse: A Laboratory Model - 1
NCT00000212 ·Status: COMPLETED ·Phase: PHASE2
-
Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1
NCT00040066 ·Status: UNKNOWN ·Phase: PHASE1
-
Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4
NCT00000301 ·Status: COMPLETED ·Phase: PHASE2
-
Cocaine Abuse and Attention Deficit Disorder - 3
NCT00000268 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Memantine in Treating Cocaine-Dependent Individuals - 2
NCT00134901 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1
NCT00067535 ·Status: COMPLETED ·Phase: PHASE1
-
Treating Cocaine Abuse: A Behavioral Approach
NCT01822327 ·Status: UNKNOWN ·Phase: PHASE2
-
A Feasibility Trial for Inhibitory-Control Training to Reduce Cocaine Use
NCT02444208 ·Status: COMPLETED ·Phase: NA
-
Cocaine Abuse and ADHD - 10
NCT00000275 ·Status: COMPLETED ·Phase: PHASE2
-
Behavioral Effects of Drugs (Inpatient): 38
NCT03954938 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Cognitive Enhancement as a Target for Cocaine Pharmacotherapy
NCT01531153 ·Status: COMPLETED ·Phase: NA
-
Therapeutic Cocaine Vaccine: Human Laboratory Study
NCT00965263 ·Status: COMPLETED ·Phase: PHASE2
-
Brain Changes in Stimulant Dependent Subjects - 8
NCT00000343 ·Status: COMPLETED ·Phase: PHASE4
-
Cocaine Use Reduction and Health
NCT03224546 ·Status: COMPLETED ·Phase: NA
-
Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders
NCT03344419 ·Status: SUSPENDED ·Phase: PHASE3
-
A Sequenced Behavioral and Medication Intervention for Cocaine Dependence
NCT01986075 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Placebo-Controlled Double-Blind Combined Treatment of Modafinil and CBT for Cocaine Dependence
NCT00344565 ·Status: COMPLETED ·Phase: PHASE2
-
Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
NCT00000276 ·Status: TERMINATED ·Phase: PHASE1
-
IV Cocaine Abuse: A Laboratory Model - 3
NCT00000214 ·Status: COMPLETED ·Phase: PHASE2
-
Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1
NCT00094315 ·Status: UNKNOWN ·Phase: PHASE1
-
Pergolide Treatment for Substance Abusers - 4
NCT00000269 ·Status: COMPLETED ·Phase: PHASE2
-
Cocaine Cue-reactivity Incubation Study
NCT07091877 ·Status: RECRUITING ·Phase: NA
-
IV Cocaine Abuse: A Laboratory Model - 2
NCT00000213 ·Status: COMPLETED ·Phase: PHASE2
-
Early Phase II Trials for Cocaine Medication Development - 1
NCT00000317 ·Status: COMPLETED ·Phase: PHASE2
-
Alterations in Serotonergic Functions in Cocaine Addicts - 1
NCT00000312 ·Status: COMPLETED ·Phase: PHASE1